Showing results (21-30 of 552) with videos related to
Sort By:
Pageof 56
British Dental Journal|August 12, 2017
A guide to building 'MI' oral healthcare practiceB Dawett, B Atkins, A BanerjeeCurrent Opinion in Oncology|November 1, 1993
Mechanisms of action and toxicity of immunotherapy with cytokinesJ W Mier, M B AtkinsJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
Swinging for the Fences: Long-Term Survival With Ipilimumab in Metastatic MelanomaGeoffrey T Gibney, Michael B AtkinsCancer Journal (Sudbury, Mass.)|October 7, 2008
Immunotherapy of metastatic renal cell carcinomaDavid F McDermott, Michael B AtkinsExpert Review of Anticancer Therapy|December 26, 2006
Update on therapy for melanoma: opportunities for patient selection and overcoming tumor resistanceHenry B Koon, Michael B AtkinsHematology/Oncology Clinics of North America|July 19, 2011
Future directions in renal cell carcinoma: 2011 and beyondDaniel C Cho, Michael B AtkinsHormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 1, 1995
Effect of 1,10-phenanthroline on DNA binding by 1,25-(OH)2 vitamin D receptorK B Atkins, D C BeitzClinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2014
Molecular pathways: can activin-like kinase pathway inhibition enhance the limited efficacy of VEGF inhibitors?Rupal S Bhatt, Michael B AtkinsJournal of Cancer Metastasis and Treatment|March 17, 2022
Current and emerging therapies for first line treatment of metastatic clear cell renal cell carcinomaMichael T Serzan, Michael B AtkinsCancer Treatment Reviews|September 3, 2018
Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinomaMichael B Atkins, Nizar M TannirPageof 56